| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.553 | 3.947 | 3.733 | 6.841 | 3.314 | 3.283 | 3.098 | 3.178 | 3.566 | 5.018 |
| Total Income - EUR | 5.553 | 3.947 | 3.733 | 6.841 | 3.314 | 3.283 | 3.098 | 3.178 | 3.566 | 5.018 |
| Total Expenses - EUR | 5.025 | 2.741 | 2.361 | 3.120 | 2.620 | 2.274 | 5.091 | 2.022 | 1.129 | 1.880 |
| Gross Profit/Loss - EUR | 528 | 1.206 | 1.372 | 3.721 | 695 | 1.008 | -1.992 | 1.156 | 2.437 | 3.138 |
| Net Profit/Loss - EUR | 362 | 1.088 | 1.260 | 3.514 | 584 | 918 | -2.083 | 1.085 | 2.025 | 2.644 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ansa-Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.943 | 11.932 | 11.934 | 15.286 | 15.603 | 16.225 | 13.700 | 14.804 | 17.001 | 19.443 |
| Inventories | 2.870 | 3.866 | 3.273 | 3.213 | 3.150 | 3.091 | 0 | 0 | 0 | 0 |
| Receivables | 248 | 28 | 8.319 | 10.745 | 10.537 | 12.404 | 12.129 | 14.494 | 16.653 | 18.570 |
| Cash | 7.825 | 8.038 | 343 | 1.329 | 1.916 | 730 | 1.571 | 310 | 347 | 873 |
| Shareholders Funds | 9.844 | 10.831 | 11.908 | 15.204 | 15.493 | 16.117 | 13.677 | 14.804 | 16.784 | 19.335 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.099 | 1.101 | 26 | 82 | 110 | 108 | 23 | 0 | 217 | 109 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3299 - 3299" | |||||||||
| CAEN Financial Year |
3299
|
|||||||||
Comments - Ansa-Intermed Srl